España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Virtus LifeSci Biotech Clinical Trials ETF
BBC
ARCA
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$24.48
0.16
0.64%
At close: -
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for Virtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC)
Virtus LifeSci Biotech Clinical Trials ETF (ARCA: BBC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 10, 2024
Why Is uniQure Stock Skyrocketing On Tuesday?
Nabaparna Bhattacharya
Friday, July 12, 2024
Inflation Cools in June, Triggers Spike in Laggard ETFs
Zacks
Thursday, May 16, 2024
Top 10 Trending Stocks On WallStreetBets As O...
Benzinga Newsdesk
Tuesday, June 30, 2020
3 ETFs With Q2 Gains Of At Least 30%
ETF Professor
Thursday, May 07, 2020
3 Biotech ETFs Up 10% Or More Over The Last Month
ETF Professor
Saturday, December 28, 2019
5 Best ETFs Of 2019
ETF Professor
Monday, December 09, 2019
There's A Really Good Chance You Missed One Of The Year's Best ETFs
ETF Professor
Friday, October 06, 2017
Life (Science) Lessons: The Hows And Whos To Play Biotech
Benzinga
Friday, December 30, 2016
2016's Worst ETFs: International Illness And Healthcare Sickness
Benzinga
Monday, January 04, 2016
Paul Yook: Why I'm Optimistic About Biotechs
Benzinga
Anne-Marie Baiynd On Facebook, Disney And Looking Beyond Price
Benzinga
Thursday, August 27, 2015
ETFs BBP, BBC, TUTT Halted; Bank of NY Mellon...
Benzinga
Tuttle Tactical Mgmt US Core ETF, BioShares B...
Benzinga
Sunday, May 03, 2015
The Best (And Worst) ETFs Of Last Week Amid Social Media's Collapse
Benzinga
Saturday, March 28, 2015
Best And Worst ETFs Of The Week Amid Slowing Corporate Profits
Benzinga
Monday, January 26, 2015
Virtus Investment Partners to Acquire Majority Stake in ETF Issuer Solutions
Benzinga
